Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities.
Picci P, Böhling T, Bacci G, Ferrari S, Sangiorgi L, Mercuri M, Ruggieri P, Manfrini M, Ferraro A, Casadei R, Benassi MS, Mancini AF, Rosito P, Cazzola A, Barbieri E, Tienghi A, Brach del Prever A, Comandone A, Bacchini P, Bertoni F. Picci P, et al. Among authors: rosito p. J Clin Oncol. 1997 Apr;15(4):1553-9. doi: 10.1200/JCO.1997.15.4.1553. J Clin Oncol. 1997. PMID: 9193352
Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies.
Bacci G, Picci P, Ferrari S, Mercuri M, Brach del Prever A, Rosito P, Barbieri E, Tienghi A, Forni C. Bacci G, et al. Among authors: rosito p. Cancer. 1998 Mar 15;82(6):1174-83. doi: 10.1002/(sici)1097-0142(19980315)82:6<1174::aid-cncr24>3.0.co;2-2. Cancer. 1998. PMID: 9506366 Clinical Trial.
Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity.
Ferrari S, Mercuri M, Rosito P, Mancini A, Barbieri E, Longhi A, Rimondini S, Cesari M, Ruggieri P, Di Liddo M, Bacci G. Ferrari S, et al. Among authors: rosito p. J Chemother. 1998 Dec;10(6):484-91. doi: 10.1179/joc.1998.10.6.484. J Chemother. 1998. PMID: 9876058 Clinical Trial.
No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies.
Bacci G, Picci P, Ruggieri P, Ferrari S, Mercuri M, Fabbri N, Rosito P, Barbieri E, Ferraro A, Casadei R, et al. Bacci G, et al. Among authors: rosito p. J Chemother. 1993 Aug;5(4):247-57. doi: 10.1080/1120009x.1993.11739240. J Chemother. 1993. PMID: 8229153 Clinical Trial.
79 results